메뉴 건너뛰기




Volumn 40, Issue 2, 2006, Pages 323-327

Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms

Author keywords

Hepatic transaminases; Hepatotoxicity; Venlafaxine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; VENLAFAXINE;

EID: 33144485234     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G339     Document Type: Article
Times cited : (25)

References (19)
  • 1
    • 33144460273 scopus 로고    scopus 로고
    • Menopause and beyond
    • Barker LR, Burton JR, Zieve PD, eds. Philadelphia: Lippincott, Williams & Wilkins
    • Miller RG. Menopause and beyond. In: Barker LR, Burton JR, Zieve PD, eds. Principles of ambulatory medicine. 6th ed. Philadelphia: Lippincott, Williams & Wilkins, 2003.
    • (2003) Principles of Ambulatory Medicine. 6th Ed.
    • Miller, R.G.1
  • 3
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 4
    • 0034676813 scopus 로고    scopus 로고
    • Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial
    • Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-63.
    • (2000) Lancet , vol.356 , pp. 2059-2063
    • Loprinzi, C.L.1    Kugler, J.W.2    Sloan, J.A.3
  • 5
    • 0031859788 scopus 로고    scopus 로고
    • Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors
    • Loprinzi CL, Pisansky TM, Fonseca R, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998;16:237-81.
    • (1998) J Clin Oncol , vol.16 , pp. 237-281
    • Loprinzi, C.L.1    Pisansky, T.M.2    Fonseca, R.3
  • 7
    • 33144476511 scopus 로고    scopus 로고
    • Trivestin ingredients, www.4jointhealth.com/trivestin.html (accessed 2006 Jan 11).
    • Trivestin Ingredients
  • 8
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
    • (1981) Clin Pharmacol Ther , vol.30 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3
  • 9
    • 33144486562 scopus 로고    scopus 로고
    • Package insert
    • Philadelphia: Wyeth Pharmaceuticals, November
    • Package insert. Effexor XR (venlafaxine). Philadelphia: Wyeth Pharmaceuticals, November 2003.
    • (2003) Effexor XR (Venlafaxine)
  • 10
    • 0041342015 scopus 로고    scopus 로고
    • Drug-induced hepatotoxicity
    • Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-85.
    • (2003) N Engl J Med , vol.349 , pp. 474-485
    • Lee, W.M.1
  • 11
    • 0029887138 scopus 로고    scopus 로고
    • The safety and tolerability of venlafaxine hydrochloride: Analysis of the clinical trials database
    • Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol 1996;16(suppl):54S-61S.
    • (1996) J Clin Psychopharmacol , vol.16 , Issue.SUPPL.
    • Rudolph, R.L.1    Derivan, A.T.2
  • 12
    • 0038740699 scopus 로고    scopus 로고
    • Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: Data from the World Health Organization (WHO) database of adverse drug reactions
    • Spigset O, Hagg S, Bate A. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. Int Clin Psychopharmacol 2003;18:157-61.
    • (2003) Int Clin Psychopharmacol , vol.18 , pp. 157-161
    • Spigset, O.1    Hagg, S.2    Bate, A.3
  • 13
    • 0032847231 scopus 로고    scopus 로고
    • Influence of CYP2D6 activity on the disposition of the antidepressant agent venlafaxine in humans
    • Lessard E, Yessine MA, Hamelin BA, O'Hara G, LeBlanc J, Turgeon J. Influence of CYP2D6 activity on the disposition of the antidepressant agent venlafaxine in humans. Pharmacogenetics 1999;9:435-43.
    • (1999) Pharmacogenetics , vol.9 , pp. 435-443
    • Lessard, E.1    Yessine, M.A.2    Hamelin, B.A.3    O'Hara, G.4    LeBlanc, J.5    Turgeon, J.6
  • 14
    • 0036086164 scopus 로고    scopus 로고
    • Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone
    • Kohnke MD, Griese EU, Stosser D, Gaertner I, Barth G. Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone. Pharmacopsychiatry 2002;35:116-8.
    • (2002) Pharmacopsychiatry , vol.35 , pp. 116-118
    • Kohnke, M.D.1    Griese, E.U.2    Stosser, D.3    Gaertner, I.4    Barth, G.5
  • 15
    • 1642580645 scopus 로고    scopus 로고
    • Low-dose venlafaxine-associated liver toxicity in chronic hepatitis
    • Epub 23 Dec 2003. DOI 10.1345/aph.1D205
    • Sencan I, Sahin I, Ozcetin A. Low-dose venlafaxine-associated liver toxicity in chronic hepatitis (letter). Ann Pharmacother 2004;38:352-3. Epub 23 Dec 2003. DOI 10.1345/aph.1D205
    • (2004) Ann Pharmacother , vol.38 , pp. 352-353
    • Sencan, I.1    Sahin, I.2    Ozcetin, A.3
  • 16
    • 0032895772 scopus 로고    scopus 로고
    • Acute liver damage possibly related to sertraline and venlafaxine ingestion
    • DOI 10.1345/aph.18155
    • Kim KY, Hwang W, Narendran R. Acute liver damage possibly related to sertraline and venlafaxine ingestion (letter). Ann Pharmacother 1999;33:381-2. DOI 10.1345/aph.18155
    • (1999) Ann Pharmacother , vol.33 , pp. 381-382
    • Kim, K.Y.1    Hwang, W.2    Narendran, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.